Editorial: Impacts of public-private collaborative research on Alzheimer's disease: the case of the innovative medicines initiative.
Elisabetta Vaudano, Jean Georges, Martin Hofmann-Apitius, Donald Lo
Author Information
- Elisabetta Vaudano: The Innovative Health Initiative Joint Undertaking, Brussels, Belgium.
- Jean Georges: Alzheimer Europe, Luxembourg, Luxembourg.
- Martin Hofmann-Apitius: Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Bonn, Germany.
- Donald Lo: EATRIS, Amsterdam, Netherlands.
No abstract text available.
- Int J Mol Sci. 2015 Dec 07;16(12):29179-206
[PMID: 26690135]
- Lancet Public Health. 2022 Feb;7(2):e105-e125
[PMID: 34998485]
- Sci Rep. 2021 May 26;11(1):11049
[PMID: 34040048]
- Lancet Neurol. 2023 Sep;22(9):782-783
[PMID: 37463598]
- Alzheimers Dement. 2023 Feb;19(2):658-670
[PMID: 35652476]
- Patterns (N Y). 2022 Jan 26;3(3):100433
[PMID: 35510183]